메뉴 건너뛰기




Volumn 6, Issue 3, 2006, Pages 257-268

New insights into endocannabinoid degradation and its therapeutic potential

Author keywords

2 arachidonoylglycerol; Anandamide; Fatty acid amide hydrolase; Human disease; Membrane transport; Therapy

Indexed keywords

1 (20CYANO 16,16 DIMETHYLEICOSA 5,8,11,14 TETRAENOYL)GLYCEROL; 2 ARACHIDONOYLGLYCEROL; ACYLGLYCEROL LIPASE; ALPHA METHYL 1 ARACHIDONOYLGLYCEROL; AM 1172; AM 374; ANANDAMIDE; ARVANIL; CANNABIDIOL; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AFFECTING AGENT; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; ENDOCANNABINOID; FATTY ACID AMIDASE; GLUTATHIONE; HYDROLASE INHIBITOR; LIPOPROTEIN LIPASE; METHYLARACHIDONYLFLUROPHOSPHONATE; N (3 FURYLMETHYL)ARACHIDONAMIDE; N (4 HYDROXY 2 METHYLPHENYL)ARACHIDONAMIDE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; N (5 METHOXYTRYPTAMINE)ARACHIDONAMIDE; N (EICOSATETRAENYL) 4 HYDROXYBENZAMIDE; NITRIC OXIDE DONOR; O 2203; OLVANIL; OMDM 1; OMDM 2; PHOSPHOLIPASE A2 INHIBITOR; RIMONABANT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VDM 13;

EID: 33646068357     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955706776073466     Document Type: Review
Times cited : (102)

References (169)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.